The CREscendoing promise of HDAC targeting to limit atherosclerosis

Area of Science:

• Cardiovascular Biology
• Immunology
• Genetics

Background:

• The inflammatory response in atherosclerosis is not fully understood.
• Genetic factors influencing atherosclerosis risk require further investigation.

Purpose of the Study:

• To investigate the role of a specific cis-regulatory element (CRE) in controlling HDAC9 expression.
• To elucidate the mechanism by which genetic variants in this CRE impact human atherosclerosis-associated inflammation.

Main Methods:

• Analysis of a conserved cis-regulatory element (CRE) affecting HDAC9 expression.
• Investigation of HDAC9's role in NLRP3 deacetylation.
• Correlation of genetic variants with inflammatory processes in atherosclerosis.

Main Results:

• A conserved CRE significantly impacts HDAC9 expression.
• HDAC9 mediates the deacetylation of NLRP3.
• This HDAC9-mediated deacetylation is a potential mechanism linking CRE variants to atherosclerosis inflammation.

Conclusions:

• Genetic variants within a conserved CRE influence atherosclerosis by modulating HDAC9 expression.
• HDAC9-dependent NLRP3 deacetylation is identified as a key mechanism in atherosclerosis-related inflammation.